Saftey and Efficacy of Pegfilgrastim in Preventing Chrmotherapy-induced Neutropenia
Clinical trial NCT01918241 · UNKNOWN
Trial details
- NCT number
- NCT01918241
- Sponsor
- Hangzhou Jiuyuan Gene Engineering Co. Ltd.,
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2016-01-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.